Skip to content
LexBuild

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Addressing Emerging Infectious Diseases in the Republic of India, Funding Opportunity Announcement (FOA) IP 08-009

---
identifier: "/us/fr/E8-9515"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Addressing Emerging Infectious Diseases in the Republic of India, Funding Opportunity Announcement (FOA) IP 08-009"
title_number: 0
title_name: "Federal Register"
section_number: "E8-9515"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Addressing Emerging Infectious Diseases in the Republic of India, Funding Opportunity Announcement (FOA) IP 08-009"
positive_law: false
currency: "2008-05-02"
last_updated: "2008-05-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E8-9515"
document_type: "notice"
publication_date: "2008-05-02"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "73 FR 24291"
fr_volume: 73
---

#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Addressing Emerging Infectious Diseases in the Republic of India, Funding Opportunity Announcement (FOA) IP 08-009

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

*Time and Date:* 12 p.m.-2 p.m., June 17, 2008 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to “Addressing Emerging Infectious Diseases in the Republic of India,” FOA IP 08-009.

*Contact Person for More Information:* Trudy Messmer, PhD, Scientific Review Administrator, Coordinating Center for Infectious Diseases, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop C19, Atlanta, GA 30333, Telephone 404-639-2176.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: April 28, 2008.

Diane Allen,

Acting Director, Management Analysis and Services Office,  Centers for Disease Control and Prevention.